semaglutide ckd trial Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo FLOW trial Ozempic® (semaglutide injection)

Espinacas y esprragos: ambos son fuentes naturales de glutatin y otros antioxidantes

51:19 (2024) Kobayashi J, Sasaki D, Hara KY, Hasunuma T, Kondo A

The authors themselves described it as a small preliminary study.[15] A 2025 pilot report described intravenous administration to two healthy adults at doses up to 20 mg, with no measurable changes in cardiac, hepatic, renal or thyroid biomarkers and no reported adverse effects.[16] Two individuals cannot characterise uncommon reactions, immunogenicity, long-term toxicity, reproductive safety or oncological risk

Researches regarding the microbiota of the homemade bors, as healthy source

Acta Medica Port